NCT00492271View on ClinicalTrials.gov

First Time in Man Trial for Friulimicin B

PHASE1TerminatedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Community Acquired PneumoniaStaphylococcal Skin Infections
Interventions
DRUG

Friulimicin B

Intravenous, once daily, single dose

Trial Locations (1)

CH-4123

Swiss Pharma Contract Ltd, Basel

Sponsors
All Listed Sponsors
lead

MerLion Pharmaceuticals GmbH

INDUSTRY

NCT00492271 - First Time in Man Trial for Friulimicin B | Biotech Hunter | Biotech Hunter